Metformin Inhibits the Development of Hypopharyngeal Squamous Cell Carcinoma through Circ_0003214-Mediated MiR-489-3p-ADAM10 Pathway

CONCLUSION: Metformin inhibits HSCC progression through the circ_0003214/miR-489-3p/ADAM10 pathway.PMID:34335751 | PMC:PMC8295003 | DOI:10.1155/2021/2265475
Source: Journal of Oncology - Category: Cancer & Oncology Authors: Source Type: research